A United Kingdom supplier, with 2 awarded contracts, totalling £181.1m, most recently 3 months ago.
This public procurement contract involves the supply of a cancer treatment drug intended for the therapy of malignant blood diseases. The total expected volume is 32 individual doses of the drug. This medication will be used in healthcare services at the FN Plzeň medical facility. Deliveries will be
This public procurement contract involves the ongoing supply of medicinal products containing the active ingredient A05AX07 SELADELPAR for a duration of 4 years. The contract is valued at approximately 16,328,875.68 EUR and is intended for health services. Suppliers interested in this opportunity ca
